Verenium Soars on Asset Sales (VRNM, CDXS, SZYM)
Enzyme commercialization company Verenium Corp. (NASDAQ: VRNM) has announced the sale of several of its assets to Dutch firm DSM Food Specialties B.V., a business group of Royal DSM. The sale includes Verenium’s oilseed processing business, licenses for some enzymes…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Verenium’s big product was supposed to be an enzyme to speed up and maker cheaper the manufacture of cellulosic ethanol. Like other custom enzyme companies such as Codexis Inc. (NASDAQ: CDXS) and Solazyme Inc. (NASDAQ: SZYM), Verenium has had to turn to food and other products to make ends meet until the ethanol ship comes in.
Investors are very happy with the sale. Just before the market opens this morning, Verenium’s shares are up more than 36% at $4.20, which will be a new 52-week high if it holds.
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.